Effects of Anti-CD 18 and LPS on CD 14 Expression on Human Monocytes |
| |
Authors: | M. OTTERLEI A. SUNDAN L. RYAN T. ESPEVIK |
| |
Affiliation: | Institute of Cancer Research and Molecular Biology, University of Trondheim, N-7005 Trondheim, Norway |
| |
Abstract: | In this study we show that the cytokine stimulatory effect of LPS on human monocytes is enhanced by addition of monoclonal antibodies against CD18 (aCD18 MoAbs). Incubation of monocytes with αCD18 MoAbs overnight increased the CD 14 expression as detected by Leu-M3, but not with My-4. These results indicate that CD18 participates in LPS-induced TNF-o production as well as in regulating CD14 expression on monocytes. Addition of LPS to monocytes resulted in a reduction in the CD14 expression after 1/2, 1, 2 and 4h, but increased CD 14 expression was seen after LPS stimulation overnight. By doing double labelling of the monocyte population for CD 14 and CD16 it was found that the reduction in CD 14 expression occurred in the CD14+/CD16+ sub-population, while the increase in CD14 expression was seen in both the CD14+/CD16+ and the CD14+/CD16+ cells. αCDU MoAbs that were able to inhibit LPS-induced cytokine production from monocytes (3C10 and My-4) were considerably less able to detect the increase in CD14 expression after LPS stimulation than aCD14 MoAbs that did not inhibit LPS-induced cytokine production (Leu-M3 and αCD14serva)- Our data indicate that My-4 and Leu-M3 define two populations of CD14+ cells on LPS stimulated human monocytes. |
| |
Keywords: | |
|
|